Evidence map›Paper›PMID 35657343›Full record

ArticleInternational journal of cancer2022

The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study.

Zeni Wu, Doratha A Byrd, Yunhu Wan, Daniel Ansong, Joe-Nat Clegg-Lamptey, Beatrice Wiafe-Addai, Lawrence Edusei, Ernest Adjei, Nicholas Titiloye, Florence Dedey and 21 more

Open access · greenAbstract read
In one paragraph

Article in International journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Identify contaminants with decontam on the QIIME 2 Framework.Microbiology resource announcements · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Response to Hanif and Sholihah.Journal of the National Cancer Institute · 2025
    Article
  10. Sample Size Estimations Based on Human Microbiome Temporal Stability Over 6 Months: A Shallow Shotgun Metagenome Sequencing Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Breast Cancer: Extracellular Matrix and Microbiome Interactions.International journal of molecular sciences · 2024
    Review
  15. Cells · 2024
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 9 institutions in 3 countries.

Zeni WuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0002-1874-2649
Doratha A ByrdDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Yunhu WanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Daniel AnsongKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Joe-Nat Clegg-LampteyKorle Bu Teaching Hospital, Accra, Ghana.
Beatrice Wiafe-AddaiPeace and Love Hospital, Kumasi, Ghana.
Lawrence EduseiKorle Bu Teaching Hospital, Accra, Ghana.
Ernest AdjeiKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Nicholas TitiloyeKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Florence DedeyKorle Bu Teaching Hospital, Accra, Ghana.
Francis AitpillahKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Joseph OppongKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Verna VanderpuyeKorle Bu Teaching Hospital, Accra, Ghana.
Ernest Osei-BonsuKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Casey L DagnallDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Kristine JonesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Amy HutchinsonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Belynda D HicksDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Thomas U AhearnDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Jianxin ShiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Rob KnightDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.
Richard BiritwumUniversity of Ghana, Accra, Ghana.
Joel YarneyKorle Bu Teaching Hospital, Accra, Ghana.
Seth WiafeSchool of Public Health, Loma Linda University, Loma Linda, California, USA.
Baffour AwuahKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Kofi NyarkoUniversity of Ghana, Accra, Ghana.
Jonine D FigueroaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0002-5100-623X
Rashmi SinhaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Montserrat Garcia-ClosasDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Louise A BrintonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Emily VogtmannDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0003-1355-5593
National Cancer Institute · USKomfo Anokye Teaching Hospital · GHKorle Bu Teaching Hospital · GHFrederick National Laboratory for Cancer Research · USUniversity of Ghana · GHLoma Linda University · USMoffitt Cancer Center · USUniversity of California San Diego · USWest End Hospital · GH

Funding

Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
Human microbiome and cancerZIACP010215 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI VOGTMANN, EMILY · 2010 to 2025
$5.3M
Intramural NIH HHS ZIA CP010215
6 · The paper itself

Abstract

The oral microbiome, like the fecal microbiome, may be related to breast cancer risk. Therefore, we investigated whether the oral microbiome was associated with breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in a case-control study in Ghana. A total of 881 women were included (369 breast cancers, 93 nonmalignant cases and 419 population-based controls). The V4 region of the 16S rRNA gene was sequenced from oral and fecal samples. Alpha-diversity (observed amplicon sequence variants [ASVs], Shannon index and Faith's Phylogenetic Diversity) and beta-diversity (Bray-Curtis, Jaccard and weighted and unweighted UniFrac) metrics were computed. MiRKAT and logistic regression models were used to investigate the case-control associations. Oral sample alpha-diversity was inversely associated with breast cancer and nonmalignant breast disease with odds ratios (95% CIs) per every 10 observed ASVs of 0.86 (0.83-0.89) and 0.79 (0.73-0.85), respectively, compared to controls. Beta-diversity was also associated with breast cancer and nonmalignant breast disease compared to controls (P ≤ .001). The relative abundances of Porphyromonas and Fusobacterium were lower for breast cancer cases compared to controls. Alpha-diversity and presence/relative abundance of specific genera from the oral and fecal microbiome were strongly correlated among breast cancer cases, but weakly correlated among controls. Particularly, the relative abundance of oral Porphyromonas was strongly, inversely correlated with fecal Bacteroides among breast cancer cases (r = -.37, P ≤ .001). Many oral microbial metrics were strongly associated with breast cancer and nonmalignant breast disease, and strongly correlated with fecal microbiome among breast cancer cases, but not controls.

Indexed as

Breast NeoplasmsGastrointestinal MicrobiomeMicrobiotaCase-Control StudiesFecesFemaleGhanaHumansLogistic ModelsPhylogenyRNA, Ribosomal, 16SRNA, Ribosomal, 16Sbreast cancerfecal microbiomeGhananonmalignant breast diseasesoral microbiome

Identifiers

PMID35657343
PMCPMC9420782
OpenAlexW4281706519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.